{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:49:00Z","timestamp":1793245740834,"version":"4.5.0"},"reference-count":179,"publisher":"Walter de Gruyter GmbH","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autism spectrum disorder (ASD) is a condition that is defined by difficulties in social interactions, communication challenges, and repetitive behaviors. ASD is a common condition, with a significant rise in the number of diagnosed children observed in recent decades. As of 2021, it is estimated that 1 in 44 children in the USA is affected by ASD. The disorder shows a notably higher prevalence in boys compared to girls, with a ratio exceeding four to one. Several genetic changes have been linked to ASD. Various common gene variations are believed to influence the likelihood of developing the condition. Genetic factors are estimated to contribute to 40\u201380\u202f% of the overall risk associated with ASD. The combined risk from genetic variations along with environmental influences\u00a0\u2013\u00a0such as older parental age, birth complications, and various unknown factors\u00a0\u2013\u00a0determines an individual\u2019s likelihood of developing this intricate condition. Many of the genes associated with ASD play a role in processes related to brain development. The proteins encoded by these genes impact various elements of brain development, including the proliferation, growth, and organization of neurons and synaptogenesis. Some genes control the number of neurons produced, while others are essential for the development and functioning of synapses. Numerous studies have been conducted to investigate the relationship between genetic variants and the risk of ASD. In this article, we discuss the functions of key genes associated with synapse formation and environmental factors including valproic acid and immunological perturbation with the development of\u00a0ASD.<\/jats:p>","DOI":"10.1515\/revneuro-2025-0040","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T19:57:56Z","timestamp":1753300676000},"page":"881-900","source":"Crossref","is-referenced-by-count":9,"title":["Autism spectrum disorder genetics; a comprehensive review"],"prefix":"10.1515","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4226-2426","authenticated-orcid":false,"given":"Farhad","family":"Mashayekhi","sequence":"first","affiliation":[{"name":"Department of Biology, Faculty of Sciences , 125585 University of Guilan , Rasht , 4193833697 , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zivar","family":"Salehi","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Sciences , 125585 University of Guilan , Rasht , 4193833697 , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"2025121816130086355_j_revneuro-2025-0040_ref_001","doi-asserted-by":"crossref","unstructured":"Abedini, M., Mashayekhi, F., and Salehi, Z. (2022). Analysis of insulin-like growth factor-1 serum levels and promoter (rs12579108) polymorphism in the children with autism spectrum disorders. J.\u00a0Clin. Neurosci. 99: 289\u2013293, https:\/\/doi.org\/10.1016\/j.jocn.2022.03.031.","DOI":"10.1016\/j.jocn.2022.03.031"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_002","doi-asserted-by":"crossref","unstructured":"Abutaleb, S., Mallah, E., Abu-Qatouseh, L., Abu-Awwad, A., Mansoor, K., Khallad, S., Omari, K.W., Mouhtady, O., and Arafat, T. (2025). Valproic acid levels in neurodevelopmental disorders: correlation with CYP and SULT genes using LC-MS\/MS. BMC Neurol. 25: 93, https:\/\/doi.org\/10.1186\/s12883-025-04065-z.","DOI":"10.1186\/s12883-025-04065-z"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_003","doi-asserted-by":"crossref","unstructured":"Akbarian, S. and Huang, H.-S. (2006). Molecular and cellular mechanisms of altered GAD1\/GAD67 expression in schizophrenia and related disorders. Brain Res. Rev. 52: 293\u2013304, https:\/\/doi.org\/10.1016\/j.brainresrev.2006.04.001.","DOI":"10.1016\/j.brainresrev.2006.04.001"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_004","doi-asserted-by":"crossref","unstructured":"Akter, M., Khan, S.F., Sajib, A.A., and Rima, F.S. (2022). A comprehensive in\u00a0silico analysis of the deleterious nonsynonymous SNPs of human FOXP2 protein. PLoS One 17: e0272625, https:\/\/doi.org\/10.1371\/journal.pone.0272625.","DOI":"10.1371\/journal.pone.0272625"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_005","doi-asserted-by":"crossref","unstructured":"Al-Ali, Z., Yasseen, A.A., Al-Dujailli, A., Al-Karaqully, A.J., McAllister, K.A., and Jumaah, A.S. (2022). The oxytocin receptor gene polymorphism rs2268491 and serum oxytocin alterations are indicative of autism spectrum disorder: a case-control paediatric study in Iraq with personalized medicine implications. PLoS One 17: e0265217, https:\/\/doi.org\/10.1371\/journal.pone.0265217.","DOI":"10.1371\/journal.pone.0265217"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_006","doi-asserted-by":"crossref","unstructured":"Alayadhi, L.Y., Halepoto, D.M., Alhowikan, A.M., Elamin, N.E., and Halepota, A.T. (2024). Low plasma levels of contactin-associated protein-like 2 in children with autism spectrum disorder: links to neural development. Neuropsychiatric Dis. Treat.: 2423\u20132431, https:\/\/doi.org\/10.2147\/ndt.s490582.","DOI":"10.2147\/NDT.S490582"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_007","doi-asserted-by":"crossref","unstructured":"Ali, Z.A., Yasseen, A.A., McAllister, K.A., Al-Dujailli, A., Al-Karaqully, A.J., and Jumaah, A.S. (2022). SNP-PCR genotyping links alterations in the GABAA receptor (GABRG3: rs208129) and RELN (rs73670) genes to autism spectrum disorder among peadiatric Iraqi Arabs. Mol. Biol. Rep. 49: 6019\u20136028, https:\/\/doi.org\/10.1007\/s11033-022-07388-z.","DOI":"10.1007\/s11033-022-07388-z"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_008","doi-asserted-by":"crossref","unstructured":"Alonso-Gonzalez, A., Calaza, M., Rodriguez-Fontenla, C., and Carracedo, A. (2019). Novel gene-based analysis of ASD GWAS: insight into the biological role of associated genes. Front. Genet. 10: 733, https:\/\/doi.org\/10.3389\/fgene.2019.00733.","DOI":"10.3389\/fgene.2019.00733"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_009","doi-asserted-by":"crossref","unstructured":"Andari, E., Nishitani, S., Kaundinya, G., Caceres, G.A., Morrier, M.J., Ousley, O., Smith, A.K., Cubells, J.F., and Young, L.J. (2020). Epigenetic modification of the oxytocin receptor gene: implications for autism symptom severity and brain functional connectivity. Neuropsychopharmacology 45: 1150\u20131158, https:\/\/doi.org\/10.1038\/s41386-020-0610-6.","DOI":"10.1038\/s41386-020-0610-6"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_010","doi-asserted-by":"crossref","unstructured":"Baker, B.C., Mackie, F.L., Lean, S.C., Greenwood, S.L., Heazell, A.E., Forbes, K., and Jones, R.L. (2017). Placental dysfunction is associated with altered microRNA expression in pregnant women with low folate status. Mol. Nutr. Food Res. 61: 1600646, https:\/\/doi.org\/10.1002\/mnfr.201600646.","DOI":"10.1002\/mnfr.201600646"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_011","doi-asserted-by":"crossref","unstructured":"Bamford, R.A., Zuko, A., Eve, M., Sprengers, J.J., Post, H., Taggenbrock, R.L., F\u00e4\u03b2ler, D., Mehr, A., Jones, O.J., Kudzinskas, A., et al.. (2024). CNTN4 modulates neural elongation through interplay with APP. Open. Biol. 14: 240018, https:\/\/doi.org\/10.1098\/rsob.240018.","DOI":"10.1098\/rsob.240018"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_012","doi-asserted-by":"crossref","unstructured":"Baris, R.O., Sahin, N., Bilgic, A.D., Ozdemir, C., and Edgunlu, T.G. (2023). Molecular and in\u00a0silico analyses of SYN III gene variants in autism spectrum disorder. Ir. J.\u00a0Med. Sci. (1971-) 192: 2887\u20132895, https:\/\/doi.org\/10.1007\/s11845-023-03402-w.","DOI":"10.1007\/s11845-023-03402-w"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_013","doi-asserted-by":"crossref","unstructured":"Bathina, S. and Das, U.N. (2015). Brain-derived neurotrophic factor and its clinical implications. Arch. Med. Sci. 11: 1164\u20131178, https:\/\/doi.org\/10.5114\/aoms.2015.56342.","DOI":"10.5114\/aoms.2015.56342"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_014","doi-asserted-by":"crossref","unstructured":"Becker, M., Devanna, P., Fisher, S.E., and Vernes, S.C. (2018). Mapping of human FOXP2 enhancers reveals complex regulation. Front. Mol. Neurosci. 11: 47, https:\/\/doi.org\/10.3389\/fnmol.2018.00047.","DOI":"10.3389\/fnmol.2018.00047"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_015","doi-asserted-by":"crossref","unstructured":"Ben-Shalom, R., Keeshen, C.M., Berrios, K.N., An, J.Y., Sanders, S.J., and Bender, K.J. (2017). Opposing effects on NaV1. 2 function underlie differences between SCN2A variants observed in individuals with autism spectrum disorder or infantile seizures. Biol. Psychiatry 82: 224\u2013232, https:\/\/doi.org\/10.1016\/j.biopsych.2017.01.009.","DOI":"10.1016\/j.biopsych.2017.01.009"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_016","doi-asserted-by":"crossref","unstructured":"Beri, S., Tonna, N., Menozzi, G., Bonaglia, M.C., Sala, C., and Giorda, R. (2007). DNA methylation regulates tissue-specific expression of Shank3. J.\u00a0Neurochem. 101: 1380\u20131391, https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04539.x.","DOI":"10.1111\/j.1471-4159.2007.04539.x"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_017","doi-asserted-by":"crossref","unstructured":"Berryer, M.H., Hamdan, F.F., Klitten, L.L., M\u00f8ller, R.S., Carmant, L., Schwartzentruber, J., Patry, L., Dobrzeniecka, S., Rochefort, D., Neugnot-Cerioli, M., et al.. (2013). Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency. Hum. Mutat. 34: 385\u2013394, https:\/\/doi.org\/10.1002\/humu.22248.","DOI":"10.1002\/humu.22248"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_018","doi-asserted-by":"crossref","unstructured":"Birtele, M., Del Dosso, A., Xu, T., Nguyen, T., Wilkinson, B., Hosseini, N., Nguyen, S., Urenda, J.-P., Knight, G., Rojas, C., et al.. (2023). Non-synaptic function of the autism spectrum disorder-associated gene SYNGAP1 in cortical neurogenesis. Nat. Neurosci. 26: 2090\u20132103, https:\/\/doi.org\/10.1038\/s41593-023-01477-3.","DOI":"10.1038\/s41593-023-01477-3"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_019","doi-asserted-by":"crossref","unstructured":"Brassai, A., Suvanjeiev, R.-G., B\u00e1n, E.-G., and Lakatos, M. (2015). Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity. Brain Res. Bull. 112: 1\u20136, https:\/\/doi.org\/10.1016\/j.brainresbull.2014.12.007.","DOI":"10.1016\/j.brainresbull.2014.12.007"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_020","doi-asserted-by":"crossref","unstructured":"Buttensch\u00f8n, H.N., Lauritsen, M.B., Daoud, A.E., Hollegaard, M., Jorgensen, M., Tvedegaard, K., Hougaard, D., B\u00f8rglum, A., Thorsen, P., and Mors, O. (2009). A population-based association study of glutamate decarboxylase 1 as a candidate gene for autism. J.\u00a0Neural Transm. 116: 381\u2013388, https:\/\/doi.org\/10.1007\/s00702-008-0142-4.","DOI":"10.1007\/s00702-008-0142-4"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_021","doi-asserted-by":"crossref","unstructured":"Cao, B., Bauer, I.E., Sharma, A.N., Mwangi, B., Frazier, T., Lavagnino, L., Zunta-Soares, G.B., Walss-Bass, C., Glahn, D.C., Kapczinski, F., et al.. (2016). Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met\u00a0allele. Zhonghua yi xue yi Chuan xue za zhi = Zhonghua Yixue Yichuanxue Zazhi = Chin. J.\u00a0Med. Genet. 198: 198\u2013205, https:\/\/doi.org\/10.1016\/j.jad.2016.03.044.","DOI":"10.1016\/j.jad.2016.03.044"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_022","unstructured":"Cao, X., Li, J., Song, H., and Zhu, Y. (2021). Identification of a novel TBR1 gene variant in a Chinese pedigree affected with intellectual developmental disorder with autism and speech delay. Zhonghua yi xue yi Chuan xue za zhi = Zhonghua Yixue Yichuanxue Zazhi = Chin. J.\u00a0Med. Genet. 38: 933\u2013936, https:\/\/doi.org\/10.3760\/cma.j.cn511374-20201020-00732."},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_023","doi-asserted-by":"crossref","unstructured":"Cattaneo, A., Cattane, N., Begni, V., Pariante, C., and Riva, M. (2016). The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders. Transl. Psychiatry 6: e958, https:\/\/doi.org\/10.1038\/tp.2016.214.","DOI":"10.1038\/tp.2016.214"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_024","doi-asserted-by":"crossref","unstructured":"Cesca, F., Baldelli, P., Valtorta, F., and Benfenati, F. (2010). The synapsins: key actors of synapse function and plasticity. Prog. Neurobiol. 91: 313\u2013348, https:\/\/doi.org\/10.1016\/j.pneurobio.2010.04.006.","DOI":"10.1016\/j.pneurobio.2010.04.006"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_025","doi-asserted-by":"crossref","unstructured":"Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T., Qin, J., and Zoghbi, H.Y. (2008). MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320: 1224\u20131229, https:\/\/doi.org\/10.1126\/science.1153252.","DOI":"10.1126\/science.1153252"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_026","doi-asserted-by":"crossref","unstructured":"Chaudhary, P., Proulx, J., and Park, I.-W. (2023). Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases. Virus Res. 335: 199191, https:\/\/doi.org\/10.1016\/j.virusres.2023.199191.","DOI":"10.1016\/j.virusres.2023.199191"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_027","doi-asserted-by":"crossref","unstructured":"Che, F., Li, C., Zhang, L., Qian, C., Mo, L., Li, B., Wu, H., Wang, L., and Yang, Y. (2024). Novel FOXP2 variant associated with speech and language dysfunction in a Chinese family and literature review. J.\u00a0Appl. Genet. 65: 367\u2013373, https:\/\/doi.org\/10.1007\/s13353-024-00849-0.","DOI":"10.1007\/s13353-024-00849-0"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_028","doi-asserted-by":"crossref","unstructured":"Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Griffith, E.C., Jaenisch, R., and Greenberg, M.E. (2003). Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302: 885\u2013889, https:\/\/doi.org\/10.1126\/science.1086446.","DOI":"10.1126\/science.1086446"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_029","doi-asserted-by":"crossref","unstructured":"Chen, C., Huang, C., Cheng, M., Chiu, Y., Tsai, W., Wu, Y., Liu, S., and Gau, S. (2014). Genetic analysis of GABRB3 as a candidate gene of autism spectrum disorders. Mol. Autism 5: 36, https:\/\/doi.org\/10.1186\/2040-2392-5-36.","DOI":"10.1186\/2040-2392-5-36"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_030","doi-asserted-by":"crossref","unstructured":"Chen, Y., Li, W., Lv, L., and Yue, W. (2024). Shared genetic determinants of schizophrenia and autism spectrum disorder implicate opposite risk patterns: a genome-wide analysis of common variants. Schizophr. Bull. 50: 1382\u20131395, https:\/\/doi.org\/10.1093\/schbul\/sbae044.","DOI":"10.1093\/schbul\/sbae044"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_031","doi-asserted-by":"crossref","unstructured":"Chen, P., Liu, Z., Zhang, Q., Lin, D., Song, L., Liu, J., Jiao, H.-F., Lai, X., Zou, S., Wang, S., et al.. (2022). DSCAM deficiency leads to premature spine maturation and autism-like behaviors. J.\u00a0Neurosci. 42: 532\u2013551, https:\/\/doi.org\/10.1523\/jneurosci.1003-21.2021.","DOI":"10.1523\/JNEUROSCI.1003-21.2021"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_032","doi-asserted-by":"crossref","unstructured":"Chien, W.-H., Chen, C.-H., Cheng, M.-C., Wu, Y.-Y., and Gau, S.S.-F. (2024). Neuregulin 2 is a candidate gene for autism spectrum disorder. Int. J.\u00a0Mol. Sci. 25: 5547, https:\/\/doi.org\/10.3390\/ijms25105547.","DOI":"10.3390\/ijms25105547"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_033","doi-asserted-by":"crossref","unstructured":"Chien, Y.-L., Chen, Y.-C., Chiu, Y.-N., Tsai, W.-C., and Gau, S.S.-F. (2021). A translational exploration of the effects of WNT2 variants on altered cortical structures in autism spectrum disorder. Am. J.\u00a0Psychiatr. Neurosci. 46: E647\u2013E658, https:\/\/doi.org\/10.1503\/jpn.210022.","DOI":"10.1503\/jpn.210022"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_034","doi-asserted-by":"crossref","unstructured":"Cortes, D.E., Escudero, M., Korgan, A.C., Mitra, A., Edwards, A., Aydin, S.C., Munger, S.C., Charland, K., Zhang, Z.-W., O\u2019Connell, K.M., et al.. (2024). An in\u00a0vitro neurogenetics platform for precision disease modeling in the mouse. Sci. Adv. 10: eadj9305, https:\/\/doi.org\/10.1126\/sciadv.adj9305.","DOI":"10.1126\/sciadv.adj9305"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_035","doi-asserted-by":"crossref","unstructured":"Coskunpinar, E.M., Tur, S., Binici, N.C., and Song\u00fcr, C.Y. (2023). Association of GABRG3, GABRB3, HTR2A gene variants with autism spectrum disorder. Gene 870: 147399, https:\/\/doi.org\/10.1016\/j.gene.2023.147399.","DOI":"10.1016\/j.gene.2023.147399"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_036","doi-asserted-by":"crossref","unstructured":"Crespo, I., Pignatelli, J., Kinare, V., M\u00e9ndez-G\u00f3mez, H.R., Esgleas, M., Rom\u00e1n, M.J., Canals, J.M., Tole, S., and Vicario, C. (2022). Tbr1 misexpression alters neuronal development in the cerebral cortex. Mol. Neurobiol. 59: 5750\u20135765, https:\/\/doi.org\/10.1007\/s12035-022-02936-x.","DOI":"10.1007\/s12035-022-02936-x"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_037","doi-asserted-by":"crossref","unstructured":"D\u2019Arcangelo, G., G. Miao, G., Chen, S.-C., Scares, H.D., Morgan, J.I., and Curran, T. (1995). A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature, 374, 719-723, https:\/\/doi.org\/10.1038\/374719a0.","DOI":"10.1038\/374719a0"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_038","doi-asserted-by":"crossref","unstructured":"de Lima Kaminski, V., Kulmann-Leal, B., Tyska-Nunes, G.L., Beltrame, B.P., dos Santos Riesgo, R., Sch\u00fcler-Faccini, L., Roman, T., Schuch, J.B., and Chies, J.A.B. (2023). Association between NKG2\/KLR gene variants and epilepsy in autism spectrum disorder. J.\u00a0Neuroimmunol. 381: 578132, https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578132.","DOI":"10.1016\/j.jneuroim.2023.578132"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_039","doi-asserted-by":"crossref","unstructured":"De Rubeis, S., He, X., Goldberg, A.P., Poultney, C.S., Samocha, K., Ercument Cicek, A., Kou, Y., Liu, L., Fromer, M., Walker, S., et al.. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515: 209\u2013215, https:\/\/doi.org\/10.1038\/nature13772.","DOI":"10.1038\/nature13772"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_040","doi-asserted-by":"crossref","unstructured":"Dhananjayan, S.C., Ramamoorthy, S., Khan, O.Y., Ismail, A., Sun, J., Slingerland, J., O\u2019Malley, B.W., and Nawaz, Z. (2006). WW domain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors. Mol. Endocrinol. 20: 2343\u20132354, https:\/\/doi.org\/10.1210\/me.2005-0533.","DOI":"10.1210\/me.2005-0533"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_041","doi-asserted-by":"crossref","unstructured":"Dodge, A., Willman, J., Willman, M., Nenninger, A.W., Morrill, N.K., Lamens, K., Greene, H., Weeber, E.J., and Nash, K.R. (2021). Identification of UBE3A protein in CSF and extracellular space of the hippocampus suggest a potential novel function in synaptic plasticity. Autism Res. 14: 645\u2013655, https:\/\/doi.org\/10.1002\/aur.2475.","DOI":"10.1002\/aur.2475"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_042","doi-asserted-by":"crossref","unstructured":"Doldur-Balli, F., Imamura, T., Veatch, O.J., Gong, N.N., Lim, D.C., Hart, M.P., Abel, T., Kayser, M.S., Brodkin, E.S., and Pack, A.I. (2022). Synaptic dysfunction connects autism spectrum disorder and sleep disturbances: a perspective from studies in model organisms. Sleep Med. Rev. 62: 101595, https:\/\/doi.org\/10.1016\/j.smrv.2022.101595.","DOI":"10.1016\/j.smrv.2022.101595"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_043","doi-asserted-by":"crossref","unstructured":"Durand, C.M., Betancur, C., Boeckers, T.M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I.C., Anckars\u00e4ter, H., et al.. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39: 25\u201327, https:\/\/doi.org\/10.1038\/ng1933.","DOI":"10.1038\/ng1933"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_044","doi-asserted-by":"crossref","unstructured":"Fang, Y., Cui, Y., Yin, Z., Hou, M., Guo, P., Wang, H., Liu, N., Cai, C., and Wang, M. (2023). Comprehensive systematic review and meta-analysis of the association between common genetic variants and autism spectrum disorder. Gene 887: 147723, https:\/\/doi.org\/10.1016\/j.gene.2023.147723.","DOI":"10.1016\/j.gene.2023.147723"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_045","doi-asserted-by":"crossref","unstructured":"Fatemi, S.H., Halt, A.R., Stary, J.M., Kanodia, R., Schulz, S.C., and Realmuto, G.R. (2002). Glutamic acid decarboxylase 65 and 67\u00a0kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52: 805\u2013810, https:\/\/doi.org\/10.1016\/s0006-3223-02-01430-0.","DOI":"10.1016\/S0006-3223(02)01430-0"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_046","doi-asserted-by":"crossref","unstructured":"Fatemi, S.H., Reutiman, T.J., Folsom, T.D., Rustan, O.G., Rooney, R.J., and Thuras, P.D. (2014). Downregulation of GABA A receptor protein subunits \u03b16, \u03b22, \u03b4, \u03b5, \u03b32, \u03b8, and \u03c12 in superior frontal cortex of subjects with autism. J.\u00a0Autism Dev. Disord. 44: 1833\u20131845, https:\/\/doi.org\/10.1007\/s10803-014-2078-x.","DOI":"10.1007\/s10803-014-2078-x"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_047","doi-asserted-by":"crossref","unstructured":"Fatemi, S.H., Snow, A.V., Stary, J.M., Araghi-Niknam, M., Reutiman, T.J., Lee, S., Brooks, A.I., and Pearce, D.A. (2005). Reelin signaling is impaired in autism. Biol. Psychiatry 57: 777\u2013787, https:\/\/doi.org\/10.1016\/j.biopsych.2004.12.018.","DOI":"10.1016\/j.biopsych.2004.12.018"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_048","doi-asserted-by":"crossref","unstructured":"Fazel Darbandi, S., Nelson, A.D., Pai, E.L.-l., Bender, K.J., and Rubenstein, J.L. (2022). LiCl treatment leads to long-term restoration of spine maturation and synaptogenesis in adult Tbr1 mutants. J.\u00a0Neurodev. Disord. 14: 11, https:\/\/doi.org\/10.1186\/s11689-022-09421-5.","DOI":"10.1186\/s11689-022-09421-5"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_049","doi-asserted-by":"crossref","unstructured":"Filice, F., Janickova, L., Henzi, T., Bilella, A., and Schwaller, B. (2020). The parvalbumin hypothesis of autism spectrum disorder. Front. Cell. Neurosci. 14: 577525, https:\/\/doi.org\/10.3389\/fncel.2020.577525.","DOI":"10.3389\/fncel.2020.577525"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_050","doi-asserted-by":"crossref","unstructured":"Foa, L. and Gasperini, R. (2009). Developmental roles for homer: more than just a pretty scaffold. J.\u00a0Neurochem. 108: 1\u201310, https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05726.x.","DOI":"10.1111\/j.1471-4159.2008.05726.x"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_051","doi-asserted-by":"crossref","unstructured":"Folsom, T.D. and Fatemi, S.H. (2013). The involvement of reelin in neurodevelopmental disorders. Neuropharmacology 68: 122\u2013135, https:\/\/doi.org\/10.1016\/j.neuropharm.2012.08.015.","DOI":"10.1016\/j.neuropharm.2012.08.015"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_052","doi-asserted-by":"crossref","unstructured":"Fornasiero, E.F., Bonanomi, D., Benfenati, F., and Valtorta, F. (2010). The role of synapsins in neuronal development. Front. Cell. Neurosci. 67: 1383\u20131396, https:\/\/doi.org\/10.1007\/s00018-009-0227-8.","DOI":"10.1007\/s00018-009-0227-8"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_053","doi-asserted-by":"crossref","unstructured":"Fujiwara, T., Morisaki, N., Honda, Y., Sampei, M., and Tani, Y. (2016). Chemicals, nutrition, and autism spectrum disorder: a mini-review. Front. Neurosci. 10: 174, https:\/\/doi.org\/10.3389\/fnins.2016.00174.","DOI":"10.3389\/fnins.2016.00174"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_054","doi-asserted-by":"crossref","unstructured":"Furman, D.J., Chen, M.C., and Gotlib, I.H. (2011). Variant in oxytocin receptor gene is associated with amygdala volume. Psychoneuroendocrinology 36: 891\u2013897, https:\/\/doi.org\/10.1016\/j.psyneuen.2010.12.004.","DOI":"10.1016\/j.psyneuen.2010.12.004"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_055","doi-asserted-by":"crossref","unstructured":"Gholipour, P., Ebrahimi, Z., Mohammadkhani, R., Ghahremani, R., Salehi, I., Sarihi, A., Komaki, A., and Karimi, S.A. (2024). Effects of (S)-3, 4-DCPG, an mGlu8 receptor agonist, on hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in prenatal valproic acid-induced rat model of autism. Sci. Rep. 14: 13168, https:\/\/doi.org\/10.1038\/s41598-024-63728-y.","DOI":"10.1038\/s41598-024-63728-y"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_056","doi-asserted-by":"crossref","unstructured":"Gifford, J.J., Deshpande, P., Mehta, P., Wagner, G.C., and Kusnecov, A.W. (2022). The effect of valproic acid exposure throughout development on microglia number in the prefrontal cortex, hippocampus and cerebellum. Neuroscience 481: 166\u2013177, https:\/\/doi.org\/10.1016\/j.neuroscience.2021.11.012.","DOI":"10.1016\/j.neuroscience.2021.11.012"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_057","doi-asserted-by":"crossref","unstructured":"Gioved\u00ed, S., Corradi, A., Fassio, A., and Benfenati, F. (2014). Involvement of synaptic genes in the pathogenesis of autism spectrum disorders: the case of synapsins. Frontiers in Pediatrics 2: 94, https:\/\/doi.org\/10.3389\/fped.2014.00094.","DOI":"10.3389\/fped.2014.00094"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_058","doi-asserted-by":"crossref","unstructured":"Greco, B., Manag\u00f2, F., Tucci, V., Kao, H.-T., Valtorta, F., and Benfenati, F. (2013). Autism-related behavioral abnormalities in synapsin knockout mice. Behav. Brain Res. 251: 65\u201374, https:\/\/doi.org\/10.1016\/j.bbr.2012.12.015.","DOI":"10.1016\/j.bbr.2012.12.015"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_059","doi-asserted-by":"crossref","unstructured":"Haghiri, R., Mashayekhi, F., Bidabadi, E., and Salehi, Z. (2016). Analysis of methionine synthase (rs1805087) gene polymorphism in autism patients in Northern Iran. Acta Neurobiol. Exp. 76: 318\u2013323, https:\/\/doi.org\/10.21307\/ane-2017-030.","DOI":"10.21307\/ane-2017-030"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_060","doi-asserted-by":"crossref","unstructured":"Harris, E., Myers, H., Saxena, K., Mitchell-Heggs, R., Kind, P., Chattarji, S., and Morris, R.G. (2021). Experiential modulation of social dominance in a SYNGAP1 rat model of autism spectrum disorders. Eur. J.\u00a0Neurosci. 54: 7733\u20137748, https:\/\/doi.org\/10.1111\/ejn.15500.","DOI":"10.1111\/ejn.15500"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_061","doi-asserted-by":"crossref","unstructured":"Hergenreder, T., Yang, T., and Ye, B. (2024). The role of Down syndrome cell adhesion molecule in Down syndrome. Med. Rev. 4: 31\u201341, https:\/\/doi.org\/10.1515\/mr-2023-0056.","DOI":"10.1515\/mr-2023-0056"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_062","doi-asserted-by":"crossref","unstructured":"Hosseinpour, M., Mashayekhi, F., Bidabadi, E., and Salehi, Z. (2017). Neuropilin-2 rs849563 gene variations and susceptibility to autism in Iranian population: a case-control study. Metab. Brain Dis. 32: 1471\u20131474, https:\/\/doi.org\/10.1007\/s11011-017-0024-2.","DOI":"10.1007\/s11011-017-0024-2"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_063","doi-asserted-by":"crossref","unstructured":"Hou, Q., Wang, Y., Li, Y., Chen, D., Yang, F., and Wang, S. (2018). A developmental study of abnormal behaviors and altered GABAergic signaling in the VPA-treated rat model of autism. Front. Behav. Neurosci. 12: 182, https:\/\/doi.org\/10.3389\/fnbeh.2018.00182.","DOI":"10.3389\/fnbeh.2018.00182"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_064","doi-asserted-by":"crossref","unstructured":"Huang, T.-N. and Hsueh, Y.-P. (2015). Brain-specific transcriptional regulator T-brain-1 controls brain wiring and neuronal activity in autism spectrum disorders. Front. Neurosci. 9: 406, https:\/\/doi.org\/10.3389\/fnins.2015.00406.","DOI":"10.3389\/fnins.2015.00406"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_065","doi-asserted-by":"crossref","unstructured":"Huang, Q., Pereira, A.C., Velthuis, H., Wong, N.M., Ellis, C.L., Ponteduro, F.M., Dimitrov, M., Kowalewski, L., Lythgoe, D.J., Rotaru, D., et al.. (2022). GABAB receptor modulation of visual sensory processing in adults with and without autism spectrum disorder. Sci. Transl. Med. 14: eabg7859, https:\/\/doi.org\/10.1126\/scitranslmed.abg7859.","DOI":"10.1126\/scitranslmed.abg7859"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_066","doi-asserted-by":"crossref","unstructured":"Iossifov, I., O\u2019roak, B.J., Sanders, S.J., Ronemus, M., Krumm, N., Levy, D., Stessman, H.A., Witherspoon, K.T., Vives, L., Patterson, K.E., et al.. (2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature 515: 216\u2013221, https:\/\/doi.org\/10.1038\/nature13908.","DOI":"10.1038\/nature13908"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_067","doi-asserted-by":"crossref","unstructured":"Ismail, V., Zachariassen, L.G., Godwin, A., Sahakian, M., Ellard, S., Stals, K.L., Baple, E., Brown, K.T., Foulds, N., Wheway, G., et al.. (2022). Identification and functional evaluation of GRIA1 missense and truncation variants in individuals with ID: an emerging neurodevelopmental syndrome. Am. J.\u00a0Hum. Genet. 109: 1217\u20131241, https:\/\/doi.org\/10.1016\/j.ajhg.2022.05.009.","DOI":"10.1016\/j.ajhg.2022.05.009"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_068","doi-asserted-by":"crossref","unstructured":"Iwanicki, T., Iwanicka, J., Balcerzyk-Mati\u0107, A., Jarosz, A., Nowak, T., Emich-Widera, E., Kazek, B., Kapinos-Gorczyca, A., Kapinos, M., Gawron, K., et al.. (2024). Association of CHD8 gene polymorphic variants with the clinical phenotype of autism spectrum disorder. J.\u00a0Clin. Med. 13: 7019, https:\/\/doi.org\/10.3390\/jcm13237019.","DOI":"10.3390\/jcm13237019"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_069","doi-asserted-by":"crossref","unstructured":"Jacob, S., Brune, C.W., Carter, C., Leventhal, B.L., Lord, C., and Cook, Jr, E.H. (2007). Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neurosci. Lett. 417: 6\u20139, https:\/\/doi.org\/10.1016\/j.neulet.2007.02.001.","DOI":"10.1016\/j.neulet.2007.02.001"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_070","doi-asserted-by":"crossref","unstructured":"Jang, W.E., Park, J.H., Park, G., Bang, G., Na, C.H., Kim, J.Y., Kim, K.-Y., Kim, K.P., Shin, C.Y., An, J.-Y., et al.. (2023). Cntnap2-dependent molecular networks in autism spectrum disorder revealed through an integrative multi-omics analysis. Mol. Psychiatr. 28: 810\u2013821, https:\/\/doi.org\/10.1038\/s41380-022-01822-1.","DOI":"10.1038\/s41380-022-01822-1"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_071","doi-asserted-by":"crossref","unstructured":"Jenkins, A.K., Paterson, C., Wang, Y., Hyde, T.M., Kleinman, J.E., and Law, A.J. (2016). Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging. Mol. Psychiatr. 21: 701\u2013706, https:\/\/doi.org\/10.1038\/mp.2015.107.","DOI":"10.1038\/mp.2015.107"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_072","doi-asserted-by":"crossref","unstructured":"Jew, C.P., Wu, C.-S., Sun, H., Zhu, J., Huang, J.-Y., Yu, D., Justice, N.J., and Lu, H.-C. (2013). mGluR5 ablation in cortical glutamatergic neurons increases novelty-induced locomotion. PLoS One 8: e70415, https:\/\/doi.org\/10.1371\/journal.pone.0070415.","DOI":"10.1371\/journal.pone.0070415"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_073","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez, J.A., Ptacek, T.S., Tuttle, A.H., Schmid, R.S., Moy, S.S., Simon, J.M., and Zylka, M.J. (2020). Chd8 haploinsufficiency impairs early brain development and protein homeostasis later in life. Mol. Autism 11: 1\u201315, https:\/\/doi.org\/10.1186\/s13229-020-00369-8.","DOI":"10.1186\/s13229-020-00369-8"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_074","doi-asserted-by":"crossref","unstructured":"Karki, R., Pandya, D., Elston, R.C., and Ferlini, C. (2015). Defining \u201cmutation\u201d and \u201cpolymorphism\u201d in the era of personal genomics. BMC Med. Genom. 8: 1\u20137, https:\/\/doi.org\/10.1186\/s12920-015-0115-z.","DOI":"10.1186\/s12920-015-0115-z"},{"key":"2025121816130086355_j_-2025-0040_ref_179","doi-asserted-by":"crossref","unstructured":"Khalili, M., Mashayekhi, F., and Salehi, Z. (2020). Association of hepatocyte growth factor genetic variation (S3735520) and its concentration in autism spectrum disorders: a case-control study. Caspian J. Neurol. Sci. 6: 197\u2013204, https:\/\/doi.org\/10.32598\/CJNS.6.23.6.","DOI":"10.32598\/CJNS.6.23.6"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_075","doi-asserted-by":"crossref","unstructured":"Koshimizu, H., Matsuoka, H., Nakajima, Y., Kawai, A., Ono, J., Ohta, K.i., Miki, T., Sunagawa, M., Adachi, N., and Suzuki, S. (2021). Brain\u2010derived neurotrophic factor predominantly regulates the expression of synapse\u2010related genes in the striatum: insights from in\u00a0vitro transcriptomics. Neuropsychopharmacol. Reports 41: 485\u2013495, https:\/\/doi.org\/10.1002\/npr2.12208.","DOI":"10.1002\/npr2.12208"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_076","doi-asserted-by":"crossref","unstructured":"Kurtz-Nelson, E.C., Rea, H.M., Petriceks, A.C., Hudac, C.M., Wang, T., Earl, R.K., Bernier, R.A., Eichler, E.E., and Neuhaus, E. (2023). Characterizing the autism spectrum phenotype in DYRK1A-related syndrome. Autism Res. 16: 1488\u20131500, https:\/\/doi.org\/10.1002\/aur.2995.","DOI":"10.1002\/aur.2995"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_077","doi-asserted-by":"crossref","unstructured":"Lamanna, J. and Meldolesi, J. (2024). Autism spectrum disorder: brain areas involved, neurobiological mechanisms, diagnoses and therapies. Int. J.\u00a0Mol. Sci. 25: 2423, https:\/\/doi.org\/10.3390\/ijms25042423.","DOI":"10.3390\/ijms25042423"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_078","doi-asserted-by":"crossref","unstructured":"Lao-Peregrin, C., Xiang, G., Kim, J., Srivastava, I., Fall, A.B., Gerhard, D.M., Kohtala, P., Kim, D., Song, M., Garcia-Marcos, M., et al.. (2024). Synaptic plasticity via receptor tyrosine kinase\/G-protein-coupled receptor crosstalk. Cell Rep. 43: 113595, https:\/\/doi.org\/10.1016\/j.celrep.2023.113595.","DOI":"10.1016\/j.celrep.2023.113595"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_079","doi-asserted-by":"crossref","unstructured":"Lauber, E., Filice, F., and Schwaller, B. (2018). Dysregulation of parvalbumin expression in the Cntnap2\/mouse model of autism spectrum disorder. Front. Mol. Neurosci. 11: 262, https:\/\/doi.org\/10.3389\/fnmol.2018.00262.","DOI":"10.3389\/fnmol.2018.00262"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_080","doi-asserted-by":"crossref","unstructured":"Lehr, A.W., McDaniel, K.F., and Roche, K.W. (2024). Analyses of human genetic data to identify clinically relevant domains of neuroligins. Genes 15: 1601, https:\/\/doi.org\/10.3390\/genes15121601.","DOI":"10.3390\/genes15121601"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_081","doi-asserted-by":"crossref","unstructured":"Levy, A.M., Gomez-Puertas, P., and T\u00fcmer, Z. (2022). Neurodevelopmental disorders associated with PSD-95 and its interaction partners. Int. J.\u00a0Mol. Sci. 23: 4390, https:\/\/doi.org\/10.3390\/ijms23084390.","DOI":"10.3390\/ijms23084390"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_082","doi-asserted-by":"crossref","unstructured":"Li, X., Chauhan, A., Sheikh, A.M., Patil, S., Chauhan, V., Li, X.-M., Ji, L., Brown, T., and Malik, M. (2009). Elevated immune response in the brain of autistic patients. J.\u00a0Neuroimmunol. 207: 111\u2013116, https:\/\/doi.org\/10.1016\/j.jneuroim.2008.12.002.","DOI":"10.1016\/j.jneuroim.2008.12.002"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_083","doi-asserted-by":"crossref","unstructured":"Lim, L., Mi, D., Llorca, A., and Mar\u00edn, O. (2018). Development and functional diversification of cortical interneurons. Neuron 100: 294\u2013313, https:\/\/doi.org\/10.1016\/j.neuron.2018.10.009.","DOI":"10.1016\/j.neuron.2018.10.009"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_084","doi-asserted-by":"crossref","unstructured":"Liu, C., Guo, Z., Pang, J., Zhang, Y., Yang, Z., Cao, J., and Zhang, T. (2024). Administration of atosiban, an oxytocin receptor antagonist, ameliorates autistic-like behaviors in a female rat model of valproic acid-induced autism. Behav. Brain Res. 469: 115052, https:\/\/doi.org\/10.1016\/j.bbr.2024.115052.","DOI":"10.1016\/j.bbr.2024.115052"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_085","doi-asserted-by":"crossref","unstructured":"Liu, J., Yan, J., Qu, F., Mo, W., Yu, H., Hu, P., and Zhang, Z. (2023). A pilot study on glutamate receptor and carrier gene variants and risk of childhood autism spectrum. Metab. Brain Dis. 38: 2477\u20132488, https:\/\/doi.org\/10.1007\/s11011-023-01272-w.","DOI":"10.1007\/s11011-023-01272-w"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_086","doi-asserted-by":"crossref","unstructured":"Liu, Z., Yang, X., Guo, P., Wang, F., Xia, W., Chen, Y., Zou, M., and Sun, C. (2023). The association between gene polymorphisms in voltage-gated potassium channels Kv2. 1 and Kv4. 2 and susceptibility to autism spectrum disorder. Front. Psychiatr. 13: 994166, https:\/\/doi.org\/10.3389\/fpsyt.2022.994166.","DOI":"10.3389\/fpsyt.2022.994166"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_087","doi-asserted-by":"crossref","unstructured":"Long, Z.M., Zhao, L., Jiang, R., Wang, K.J., Luo, S.F., Zheng, M., Li, X.F., and He, G.Q. (2015). Valproic acid modifies synaptic structure and accelerates neurite outgrowth via the glycogen synthase kinase-3\u03b2 signaling pathway in an Alzheimer\u2019s disease model. CNS Neurosci. Ther. 21: 887\u2013897, https:\/\/doi.org\/10.1111\/cns.12445.","DOI":"10.1111\/cns.12445"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_088","doi-asserted-by":"crossref","unstructured":"Lord, J.R., Mashayekhi, F., and Salehi, Z. (2022). How matrix metalloproteinase (MMP)-9 (rs3918242) polymorphism affects MMP-9 serum concentration and associates with autism spectrum disorders: a case-control study in Iranian population. Dev. Psychopathol. 34: 882\u2013888, https:\/\/doi.org\/10.1017\/s0954579420002102.","DOI":"10.1017\/S0954579420002102"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_089","doi-asserted-by":"crossref","unstructured":"Maenner, M.J., Shaw, K.A., Bakian, A.V., Bilder, D.A., Durkin, M.S., Esler, A., Furnier, S.M., Hallas, L., Hall-Lande, J., Hudson, A., et al.. (2021). Prevalence and characteristics of autism spectrum disorder among children aged 8\u00a0years\u00a0\u2013\u00a0autism and developmental disabilities monitoring network, 11 sites, United\u00a0States, 2018. MMWR. Surveillance Summ. 70: 1\u201316, https:\/\/doi.org\/10.15585\/mmwr.ss7011a1.","DOI":"10.15585\/mmwr.ss7011a1"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_090","doi-asserted-by":"crossref","unstructured":"Marro, S.G., Chanda, S., Yang, N., Janas, J.A., Valperga, G., Trotter, J., Zhou, B., Merrill, S., Yousif, I., Shelby, H., et al.. (2019). Neuroligin-4 regulates excitatory synaptic transmission in human neurons. Neuron 103: 617\u2013626. e616, https:\/\/doi.org\/10.1016\/j.neuron.2019.05.043.","DOI":"10.1016\/j.neuron.2019.05.043"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_091","doi-asserted-by":"crossref","unstructured":"Mashayekhi, F., Mizban, N., Bidabadi, E., and Salehi, Z. (2016). The association of SHANK3 gene polymorphism and autism. Minerva Pediatr. 73: 251\u2013255, https:\/\/doi.org\/10.23736\/s2724-5276.16.04539-4.","DOI":"10.23736\/S2724-5276.16.04539-4"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_092","doi-asserted-by":"crossref","unstructured":"Meltzer, A. and Van de Water, J. (2017). The role of the immune system in autism spectrum disorder. Neuropsychopharmacology 42: 284\u2013298, https:\/\/doi.org\/10.1038\/npp.2016.158.","DOI":"10.1038\/npp.2016.158"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_093","doi-asserted-by":"crossref","unstructured":"Mohebiany, A.N., Harroch, S., and Bouyain, S. (2013). New insights into the roles of the contactin cell adhesion molecules in neural development. Cell Adhes. Mol.: Implic. Neurol. Dis.: 165\u2013194, https:\/\/doi.org\/10.1007\/978-1-4614-8090-7-8.","DOI":"10.1007\/978-1-4614-8090-7_8"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_094","doi-asserted-by":"crossref","unstructured":"Mozzi, A., Riva, V., Forni, D., Sironi, M., Marino, C., Molteni, M., Riva, S., Guerini, F.R., Clerici, M., Cagliani, R., et al.. (2017). A common genetic variant in FOXP2 is associated with language-based learning (dis) abilities: evidence from two Italian independent samples. Am. J.\u00a0Med. Genet. Neuropsychiatr. Genet. 174: 578\u2013586, https:\/\/doi.org\/10.1002\/ajmg.b.32546.","DOI":"10.1002\/ajmg.b.32546"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_095","doi-asserted-by":"crossref","unstructured":"Nakanishi, M., Anderson, M.P., and Takumi, T. (2019). Recent genetic and functional insights in autism spectrum disorder. Curr. Opin. Neurol. 32: 627\u2013634, https:\/\/doi.org\/10.1097\/wco.0000000000000718.","DOI":"10.1097\/WCO.0000000000000718"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_096","doi-asserted-by":"crossref","unstructured":"Neff, R.C., Stangis, K.A., Beniwal, U., Hergenreder, T., Ye, B., and Murphy, G.G. (2024). Cognitive behavioral phenotyping of DSCAM heterozygosity as a model for autism spectrum disorder. Gene Brain Behav. 23: e70002, https:\/\/doi.org\/10.1111\/gbb.70002.","DOI":"10.1111\/gbb.70002"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_097","doi-asserted-by":"crossref","unstructured":"Nishiyama, M., Oshikawa, K., Tsukada, Y.-I., Nakagawa, T., Iemura, S.-I., Natsume, T., Fan, Y., Kikuchi, A., Skoultchi, A.I., and Nakayama, K.I. (2009). CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis. Nat. Cell Biol. 11: 172\u2013182, https:\/\/doi.org\/10.1038\/ncb1831.","DOI":"10.1038\/ncb1831"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_098","doi-asserted-by":"crossref","unstructured":"Nishiyama, M., Skoultchi, A.I., and Nakayama, K.I. (2012). Histone H1 recruitment by CHD8 is essential for suppression of the Wnt\u2013\u03b2-catenin signaling pathway. Molecular and cellular biology 32: 501\u2013512, https:\/\/doi.org\/10.1128\/mcb.06409-11.","DOI":"10.1128\/MCB.06409-11"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_099","doi-asserted-by":"crossref","unstructured":"Oguro-Ando, A., Bamford, R.A., Sital, W., Sprengers, J.J., Zuko, A., Matser, J.M., Oppelaar, H., Sarabdjitsingh, A., Jo\u00ebls, M., Burbach, J.P.H., et al.. (2021). Cntn4, a risk gene for neuropsychiatric disorders, modulates hippocampal synaptic plasticity and behavior. Transl. Psychiatry 11: 106, https:\/\/doi.org\/10.1038\/s41398-021-01223-y.","DOI":"10.1038\/s41398-021-01223-y"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_100","doi-asserted-by":"crossref","unstructured":"O\u2019Roak, B.J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B.P., Levy, R., Ko, A., Lee, C., Smith, J.D., et al.. (2012). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485: 246\u2013250, https:\/\/doi.org\/10.1038\/nature10989.","DOI":"10.1038\/nature10989"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_101","doi-asserted-by":"crossref","unstructured":"Park, J. and Chung, K.C. (2013). New perspectives of Dyrk1A role in neurogenesis and neuropathologic features of Down syndrome. Exp. Neurobiol. 22: 244, https:\/\/doi.org\/10.5607\/en.2013.22.4.244.","DOI":"10.5607\/en.2013.22.4.244"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_102","doi-asserted-by":"crossref","unstructured":"Park, Y., Won, S., Nam, M., Chung, J.-H., and Kwack, K. (2014). Interaction between MAOA and FOXP2 in association with autism and verbal communication in a Korean population. J.\u00a0Child Neurol. 29: NP207\u2013NP211, https:\/\/doi.org\/10.1177\/0883073813511301.","DOI":"10.1177\/0883073813511301"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_103","doi-asserted-by":"crossref","unstructured":"Pastore, S.F., Muhammad, T., Stan, C., Frankland, P.W., Hamel, P.A., and Vincent, J.B. (2023). Neuronal transcription of autism gene PTCHD1 is regulated by a conserved downstream enhancer sequence. Sci. Rep. 13: 20391, https:\/\/doi.org\/10.1038\/s41598-023-46673-0.","DOI":"10.1038\/s41598-023-46673-0"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_104","doi-asserted-by":"crossref","unstructured":"Pierzynowska, K., Gaffke, L., \u017babi\u0144ska, M., Cyske, Z., Rintz, E., Wi\u015bniewska, K., Podlacha, M., and W\u0119grzyn, G. (2023). Roles of the oxytocin receptor (OXTR) in human diseases. Int. J.\u00a0Mol. Sci. 24: 3887, https:\/\/doi.org\/10.3390\/ijms24043887.","DOI":"10.3390\/ijms24043887"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_105","doi-asserted-by":"crossref","unstructured":"Piras, I., Haapanen, L., Napolioni, V., Sacco, R., Van de Water, J., and Persico, A. (2014). Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with autism spectrum disorder. Brain Behav. Immun. 38: 91\u201399, https:\/\/doi.org\/10.1016\/j.bbi.2013.12.020.","DOI":"10.1016\/j.bbi.2013.12.020"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_106","doi-asserted-by":"crossref","unstructured":"Pouyan Mehr, D., Faraji, N., Rezaei, S., and Keshavarz, P. (2024). Single-locus and haplotype associations of GRIN2B gene with autism spectrum disorders and the demographic and clinical characteristics of patients in Guilan, Iran. J.\u00a0Autism Dev. Disord. 54: 607\u2013614, https:\/\/doi.org\/10.1007\/s10803-022-05818-2.","DOI":"10.1007\/s10803-022-05818-2"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_107","doi-asserted-by":"crossref","unstructured":"Ramaswami, G. and Geschwind, D.H. (2018). Genetics of autism spectrum disorder. Handb. Clin. Neurol. 147: 321\u2013329, https:\/\/doi.org\/10.1016\/b978-0-444-63233-3.00021-x.","DOI":"10.1016\/B978-0-444-63233-3.00021-X"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_108","doi-asserted-by":"crossref","unstructured":"Ramesh, V., Tsoukala, E., Kougianou, I., Kozic, Z., Burr, K., Viswanath, B., Hampton, D., Story, D., Reddy, B.K., Pal, R., et al.. (2024). The fragile X messenger ribonucleoprotein 1 regulates the morphology and maturation of human and rat oligodendrocytes. Glia 73: 1203\u20131220, https:\/\/doi.org\/10.1002\/glia.24680.","DOI":"10.1002\/glia.24680"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_109","doi-asserted-by":"crossref","unstructured":"Reim, D., Distler, U., Halbedl, S., Verpelli, C., Sala, C., Bockmann, J., Tenzer, S., Boeckers, T.M., and Schmeisser, M.J. (2017). Proteomic analysis of post-synaptic density fractions from Shank3 mutant mice reveals brain region specific changes relevant to autism spectrum disorder. Front. Mol. Neurosci. 10: 26, https:\/\/doi.org\/10.3389\/fnmol.2017.00026.","DOI":"10.3389\/fnmol.2017.00026"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_110","doi-asserted-by":"crossref","unstructured":"Riccomagno, M.M. and Kolodkin, A.L. (2015). Sculpting neural circuits by axon and dendrite pruning. Annu. Rev. Cell Dev. Biol. 31: 779\u2013805, https:\/\/doi.org\/10.1146\/annurev-cellbio-100913-013038.","DOI":"10.1146\/annurev-cellbio-100913-013038"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_111","doi-asserted-by":"crossref","unstructured":"Richter, J.D. and Zhao, X. (2021). The molecular biology of FMRP: new insights into fragile X syndrome. Nat. Rev. Neurosci. 22: 209\u2013222, https:\/\/doi.org\/10.1038\/s41583-021-00432-0.","DOI":"10.1038\/s41583-021-00432-0"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_112","doi-asserted-by":"crossref","unstructured":"Roy, B., Amemasor, E., Hussain, S., and Castro, K. (2023). UBE3A: the role in autism spectrum disorders (ASDs) and a potential candidate for biomarker studies and designing therapeutic strategies. Diseases 12: 7, https:\/\/doi.org\/10.3390\/diseases12010007.","DOI":"10.3390\/diseases12010007"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_113","doi-asserted-by":"crossref","unstructured":"Rupert, D.D. and Shea, S.D. (2022). Parvalbumin-positive interneurons regulate cortical sensory plasticity in adulthood and development through shared mechanisms. Front. Neural Circ. 16: 886629, https:\/\/doi.org\/10.3389\/fncir.2022.886629.","DOI":"10.3389\/fncir.2022.886629"},{"key":"2025121816130086355_j_-2025-0040_ref_178","doi-asserted-by":"crossref","unstructured":"Russo, A.J. (2013). Correlation between hepatocyte growth factor (HGF) and gamma-aminobutyric acid (GABA) plasma levels in autistic children. Biomark Insights 8: 69\u201375, https:\/\/doi.org\/10.4137\/BMI.S11448.","DOI":"10.4137\/BMI.S11448"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_114","doi-asserted-by":"crossref","unstructured":"Sabo, S.L., Lahr, J.M., Offer, M., Weekes, A.L., and Sceniak, M.P. (2023). GRIN2B-related neurodevelopmental disorder: current understanding of pathophysiological mechanisms. Front. Synaptic Neurosci. 14: 1090865, https:\/\/doi.org\/10.3389\/fnsyn.2022.1090865.","DOI":"10.3389\/fnsyn.2022.1090865"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_115","doi-asserted-by":"crossref","unstructured":"Saghazadeh, A., Ahangari, N., Hendi, K., Saleh, F., and Rezaei, N. (2017). Status of essential elements in autism spectrum disorder: systematic review and meta-analysis. Rev. Neurosci. 28: 783\u2013809, https:\/\/doi.org\/10.1515\/revneuro-2017-0015.","DOI":"10.1515\/revneuro-2017-0015"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_116","doi-asserted-by":"crossref","unstructured":"Salenius, K., V\u00e4lj\u00e4, N., Thusberg, S., Iris, F., Ladd-Acosta, C., Roos, C., Nykter, M., Fasano, A., Autio, R., and Lin, J. (2024). Exploring autism spectrum disorder and co-occurring trait associations to elucidate multivariate genetic mechanisms and insights. BMC Psychiatr. 24: 934, https:\/\/doi.org\/10.1186\/s12888-024-06392-w.","DOI":"10.1186\/s12888-024-06392-w"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_117","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Lafuente, C.L., Kalynchuk, L.E., Caruncho, H.J., and Ausi\u00f3, J. (2022). The role of MeCP2 in regulating synaptic plasticity in the context of stress and depression. Cells 11: 748, https:\/\/doi.org\/10.3390\/cells11040748.","DOI":"10.3390\/cells11040748"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_118","doi-asserted-by":"crossref","unstructured":"Santhakumar, V., Subramanian, D., Eisenberg, C., Huang, A., Baek, J., Naveed, H., Komatireddy, S., Shiflett, M., and Tran, T. (2025). Dysregulation of Neuropilin-2 expression in inhibitory neurons impairs hippocampal circuit development leading to autism-epilepsy phenotype. Mol Psychiatr. 30: 2799\u20132809, https:\/\/doi.org\/10.1038\/s41380-024-02839-4.","DOI":"10.1038\/s41380-024-02839-4"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_119","doi-asserted-by":"crossref","unstructured":"Sato, H., Abe, M., Takeuchi, H., Tomita, H., Kure, S., Kawashima, R., and Taki, Y. (2025). The RELN heterozygous single-nucleotide polymorphism rs362691 increases the prefrontal cortical thickness and modulates systemizing-related autistic tendencies in typically developing children and adolescents. Front. Neurosci. 19: 1574700, https:\/\/doi.org\/10.3389\/fnins.2025.1574700.","DOI":"10.3389\/fnins.2025.1574700"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_120","doi-asserted-by":"crossref","unstructured":"Scala, M., Grasso, E.A., Di Cara, G., Riva, A., Striano, P., and Verrotti, A. (2022). The pathophysiological link between reelin and autism: overview and new insights. Front. Genet. 13: 869002, https:\/\/doi.org\/10.3389\/fgene.2022.869002.","DOI":"10.3389\/fgene.2022.869002"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_121","doi-asserted-by":"crossref","unstructured":"Scheefhals, N., Catsburg, L.A., Westerveld, M.L., Blanpied, T.A., Hoogenraad, C.C., and MacGillavry, H.D. (2019). Shank proteins couple the endocytic zone to the postsynaptic density to control trafficking and signaling of metabotropic glutamate receptor 5. Cell Rep. 29: 258\u2013269. https:\/\/doi.org\/10.1016\/j.celrep.2019.08.102.","DOI":"10.1016\/j.celrep.2019.08.102"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_122","doi-asserted-by":"crossref","unstructured":"Schmeisser, M.J., Ey, E., Wegener, S., Bockmann, J., Stempel, A.V., Kuebler, A., Janssen, A.-L., Udvardi, P.T., Shiban, E., Spilker, C., et al.. (2012). Autistic-like behaviours and hyperactivity in mice lacking ProSAP1\/Shank2. Nature 486: 256\u2013260, https:\/\/doi.org\/10.1038\/nature11015.","DOI":"10.1038\/nature11015"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_123","doi-asserted-by":"crossref","unstructured":"Sch\u00fctt, J., Falley, K., Richter, D., Kreienkamp, H.-J., and Kindler, S. (2009). Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities. J.\u00a0Biol. Chem. 284: 25479\u201325487, https:\/\/doi.org\/10.1074\/jbc.m109.042663.","DOI":"10.1074\/jbc.M109.042663"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_124","doi-asserted-by":"crossref","unstructured":"Sener, E.F., Onal, M.G., Dal, F., Nalbantoglu, U., Ozkul, Y., Canatan, H., and Oztop, D.B. (2022). Novel alterations of CC2D1A as a candidate gene in a Turkish sample of patients with autism spectrum disorder. Int. J.\u00a0Neurosci. 132: 1072\u20131079, https:\/\/doi.org\/10.1080\/00207454.2020.1860968.","DOI":"10.1080\/00207454.2020.1860968"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_125","doi-asserted-by":"crossref","unstructured":"Shiota, Y., Nishiyama, T., Yokoyama, S., Yoshimura, Y., Hasegawa, C., Tanaka, S., Iwasaki, S., and Kikuchi, M. (2024). Association of genetic variants with autism spectrum disorder in Japanese children revealed by targeted sequencing. Front. Genet. 15: 1352480, https:\/\/doi.org\/10.3389\/fgene.2024.1352480.","DOI":"10.3389\/fgene.2024.1352480"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_126","doi-asserted-by":"crossref","unstructured":"Siddiqua, H., Akter, Y., Uddin, M.N., Kumkum, M., Hossain, M.A., Aziz, M.A., Ahmed, M.S., Chowdhury, M.A., Islam, M.S., and Marzan, L.W. (2022). SHANK3 genetic polymorphism and susceptibility to ASD: evidence from molecular, in\u00a0silico, and meta-analysis approaches. Mol. Biol. Rep. 49: 8449\u20138460, https:\/\/doi.org\/10.1007\/s11033-022-07663-z.","DOI":"10.1007\/s11033-022-07663-z"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_127","doi-asserted-by":"crossref","unstructured":"Sivasangari, K. and Rajan, K.E. (2022). Prenatal exposure to valproic acid alters reelin, NGF expressing neuron architecture and impairs social interaction in their autistic-like phenotype male offspring. Exp. Brain Res. 240: 2005\u20132016, https:\/\/doi.org\/10.1007\/s00221-022-06386-8.","DOI":"10.1007\/s00221-022-06386-8"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_128","doi-asserted-by":"crossref","unstructured":"Skogstrand, K., Hagen, C.M., Borbye-Lorenzen, N., Christiansen, M., Bybjerg-Grauholm, J., B\u00e6kvad-Hansen, M., Werge, T., B\u00f8rglum, A., Mors, O., Nordentoft, M., et al.. (2019). Reduced neonatal brain-derived neurotrophic factor is associated with autism spectrum disorders. Transl. Psychiatry 9: 252, https:\/\/doi.org\/10.1038\/s41398-019-0587-2.","DOI":"10.1038\/s41398-019-0587-2"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_129","doi-asserted-by":"crossref","unstructured":"Song, S.H. and Augustine, G.J. (2024). A role for synapsin tetramerization in synaptic vesicle clustering. J.\u00a0Physiol., https:\/\/doi.org\/10.1113\/jp286177.","DOI":"10.1113\/JP286177"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_130","doi-asserted-by":"crossref","unstructured":"Sousa, I., Clark, T.G., Toma, C., Kobayashi, K., Choma, M., Holt, R., Sykes, N.H., Lamb, J.A., Bailey, A.J., Battaglia, A., et al.. (2009). MET and autism susceptibility: family and case\u2013control studies. Eur. J.\u00a0Hum. Genet. 17: 749\u2013758, https:\/\/doi.org\/10.1038\/ejhg.2008.215.","DOI":"10.1038\/ejhg.2008.215"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_131","doi-asserted-by":"crossref","unstructured":"Srancikova, A., Bacova, Z., and Bakos, J. (2021). The epigenetic regulation of synaptic genes contributes to the etiology of autism. Rev. Neurosci. 32: 791\u2013802, https:\/\/doi.org\/10.1515\/revneuro-2021-0014.","DOI":"10.1515\/revneuro-2021-0014"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_132","doi-asserted-by":"crossref","unstructured":"St George-Hyslop, F., Haneklaus, M., Kivisild, T., and Livesey, F.J. (2023). Loss of CNTNAP2 alters human cortical excitatory neuron differentiation and neural network development. Biol. Psychiatry 94: 780\u2013791, https:\/\/doi.org\/10.1016\/j.biopsych.2023.03.014.","DOI":"10.1016\/j.biopsych.2023.03.014"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_133","doi-asserted-by":"crossref","unstructured":"Stekel, Z., Sheng, Y., and Zhang, W. (2022). The multifaceted role of the ubiquitin proteasome system in pathogenesis and diseases. Biomolecules 12: 925, https:\/\/doi.org\/10.3390\/biom12070925.","DOI":"10.3390\/biom12070925"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_134","doi-asserted-by":"crossref","unstructured":"S\u00fcdhof, T.C. (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455: 903\u2013911, https:\/\/doi.org\/10.1038\/nature07456.","DOI":"10.1038\/nature07456"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_135","doi-asserted-by":"crossref","unstructured":"Tatavarty, V., Pacheco, A.T., Kuhnle, C.G., Lin, H., Koundinya, P., Miska, N.J., Hengen, K.B., Wagner, F.F., Van Hooser, S.D., and Turrigiano, G.G. (2020). Autism-associated Shank3 is essential for homeostatic compensation in rodent V1. Neuron 106: 769\u2013777. e764.","DOI":"10.1016\/j.neuron.2020.02.033"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_136","doi-asserted-by":"crossref","unstructured":"Tisato, V., Silva, J.A., Longo, G., Gallo, I., Singh, A.V., Milani, D., and Gemmati, D. (2021). Genetics and epigenetics of one-carbon metabolism pathway in autism spectrum disorder: a sex-specific brain epigenome? Genes 12: 782, https:\/\/doi.org\/10.3390\/genes12050782.","DOI":"10.3390\/genes12050782"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_137","doi-asserted-by":"crossref","unstructured":"Tokunaga, S., Shimomura, H., Taniguchi, N., Yanagi, K., Kaname, T., Okamoto, N., and Takeshima, Y. (2024). A novel DLG4 variant causes DLG4-related synaptopathy with intellectual regression. Hum. Genome Var. 11: 1, https:\/\/doi.org\/10.1038\/s41439-023-00260-x.","DOI":"10.1038\/s41439-023-00260-x"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_138","doi-asserted-by":"crossref","unstructured":"T\u00f6nges, L., Ostendorf, T., Lamballe, F., Genestine, M., Dono, R., Koch, J.C., B\u00e4hr, M., Maina, F., and Lingor, P. (2011). Hepatocyte growth factor protects retinal ganglion cells by increasing neuronal survival and axonal regeneration in\u00a0vitro and in\u00a0vivo. J.\u00a0Neurochem. 117: 892\u2013903, https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07257.x.","DOI":"10.1111\/j.1471-4159.2011.07257.x"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_139","doi-asserted-by":"crossref","unstructured":"Tora, D., Gomez, A.M., Michaud, J.-F., Yam, P.T., Charron, F., and Scheiffele, P. (2017). Cellular functions of the autism risk factor PTCHD1 in mice. J.\u00a0Neurosci. 37: 11993\u201312005, https:\/\/doi.org\/10.1523\/jneurosci.1393-17.2017.","DOI":"10.1523\/JNEUROSCI.1393-17.2017"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_140","doi-asserted-by":"crossref","unstructured":"Toro, R., Konyukh, M., Delorme, R., Leblond, C., Chaste, P., Fauchereau, F., Coleman, M., Leboyer, M., Gillberg, C., and Bourgeron, T. (2010). Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet. 26: 363\u2013372, https:\/\/doi.org\/10.1016\/j.tig.2010.05.007.","DOI":"10.1016\/j.tig.2010.05.007"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_141","doi-asserted-by":"crossref","unstructured":"Torrico, B., Fern\u00e0ndez-Castillo, N., Herv\u00e1s, A., Mil\u00e0, M., Salgado, M., Rueda, I., Buitelaar, J.K., Rommelse, N., Oerlemans, A.M., Bralten, J., et al.. (2015). Contribution of common and rare variants of the PTCHD1 gene to autism spectrum disorders and intellectual disability. Eur. J.\u00a0Hum. Genet. 23: 1694\u20131701, https:\/\/doi.org\/10.1038\/ejhg.2015.37.","DOI":"10.1038\/ejhg.2015.37"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_142","doi-asserted-by":"crossref","unstructured":"Toya, A., Fukada, M., Aoki, E., Matsuki, T., Ueda, M., Eda, S., Hashizume, Y., Iio, A., Masaki, S., and Nakayama, A. (2023). The distribution of neuroligin4, an autism-related postsynaptic molecule, in the human brain. Mol. Brain 16: 20, https:\/\/doi.org\/10.1186\/s13041-023-00999-y.","DOI":"10.1186\/s13041-023-00999-y"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_143","doi-asserted-by":"crossref","unstructured":"Tripathi, M.K., Ojha, S.K., Kartawy, M., Khaliulin, I., Hamoudi, W., and Amal, H. (2024). Mutations associated with autism lead to similar synaptic and behavioral alterations in both sexes of male and female mouse brain. Sci. Rep. 14: 10, https:\/\/doi.org\/10.1038\/s41598-023-50248-4.","DOI":"10.1038\/s41598-023-50248-4"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_144","doi-asserted-by":"crossref","unstructured":"Ung, D., Iacono, G., M\u00e9ziane, H., Blanchard, E., Papon, M., Selten, M., van Rhijn, J., Montjean, R., Rucci, J., Martin, S., et al.. (2018). Ptchd1 deficiency induces excitatory synaptic and cognitive dysfunctions in mouse. Mol. Psychiatr. 23: 1356\u20131367, https:\/\/doi.org\/10.1038\/mp.2017.39.","DOI":"10.1038\/mp.2017.39"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_145","doi-asserted-by":"crossref","unstructured":"van Bon, B.W., Coe, B.P., Bernier, R., Green, C., Gerdts, J., Witherspoon, K., Kleefstra, T., Willemsen, M.H., Kumar, R., Bosco, P., et al.. (2016). Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID. Mol. Psychiatr. 21: 126\u2013132, https:\/\/doi.org\/10.1038\/mp.2015.5.","DOI":"10.1038\/mp.2015.5"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_146","doi-asserted-by":"crossref","unstructured":"Van Den Burg, E.H., Stindl, J., Grund, T., Neumann, I.D., and Strauss, O. (2015). Oxytocin stimulates extracellular Ca2+ influx through TRPV2 channels in hypothalamic neurons to exert its anxiolytic effects. Neuropsychopharmacology 40: 2938\u20132947, https:\/\/doi.org\/10.1038\/npp.2015.147.","DOI":"10.1038\/npp.2015.147"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_147","doi-asserted-by":"crossref","unstructured":"Vieira, M.M., Jeong, J., and Roche, K.W. (2021). The role of NMDA receptor and neuroligin rare variants in synaptic dysfunction underlying neurodevelopmental disorders. Curr. Opin. Neurobiol. 69: 93\u2013104, https:\/\/doi.org\/10.1016\/j.conb.2021.03.001.","DOI":"10.1016\/j.conb.2021.03.001"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_148","doi-asserted-by":"crossref","unstructured":"Vuu, Y.M., Roberts, C.-T., and Rastegar, M. (2023). MeCP2 is an epigenetic factor that links DNA methylation with brain metabolism. Int. J.\u00a0Mol. Sci. 24: 4218, https:\/\/doi.org\/10.3390\/ijms24044218.","DOI":"10.3390\/ijms24044218"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_149","doi-asserted-by":"crossref","unstructured":"Wang, C.-C., Chen, P.S., Hsu, C.-W., Wu, S.-J., Lin, C.-T., and Gean, P.W. (2012). Valproic acid mediates the synaptic excitatory\/inhibitory balance through astrocytes\u00a0\u2013\u00a0A preliminary study. Prog. Neuro Psychopharmacol. Biol. Psychiatr. 37: 111\u2013120, https:\/\/doi.org\/10.1016\/j.pnpbp.2012.01.017.","DOI":"10.1016\/j.pnpbp.2012.01.017"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_150","doi-asserted-by":"crossref","unstructured":"Wang, J., Gong, J., Li, L., Chen, Y., Liu, L., Gu, H., Luo, X., Hou, F., Zhang, J., and Song, R. (2018). Neurexin gene family variants as risk factors for autism spectrum disorder. Autism Res. 11: 37\u201343, https:\/\/doi.org\/10.1002\/aur.1881.","DOI":"10.1002\/aur.1881"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_151","doi-asserted-by":"crossref","unstructured":"Wang, J., Li, L., Shao, S.S., He, Z., Chen, Y.l., Kong, R., Zhang, X.H., Gong, J.H., and Song, R.R. (2016). Association analysis of genetic variant of rs13331 in PSD95 gene with autism spectrum disorders: a case-control study in a Chinese population. J.\u00a0Huazhong Univ. Sci. Technol.\u00a0\u2013\u00a0Med. Sci. 36: 285\u2013288, https:\/\/doi.org\/10.1007\/s11596-016-1581-z.","DOI":"10.1007\/s11596-016-1581-z"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_152","doi-asserted-by":"crossref","unstructured":"Weissberg, O. and Elliott, E. (2021). The mechanisms of CHD8 in neurodevelopment and autism spectrum disorders. Genes (Basel) 12: 1133, https:\/\/doi.org\/10.3390\/genes12081133.","DOI":"10.3390\/genes12081133"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_153","doi-asserted-by":"crossref","unstructured":"Werling, D.M. and Geschwind, D.H. (2013). Sex differences in autism spectrum disorders. Curr. Opin. Neurol. 26: 146\u2013153, https:\/\/doi.org\/10.1097\/wco.0b013e32835ee548.","DOI":"10.1097\/WCO.0b013e32835ee548"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_154","doi-asserted-by":"crossref","unstructured":"Willemsen, R., Levenga, J., and Oostra, B.A. (2011). CGG repeat in the FMR1 gene: size matters. Clin. Genet. 80: 214\u2013225, https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01723.x.","DOI":"10.1111\/j.1399-0004.2011.01723.x"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_155","doi-asserted-by":"crossref","unstructured":"Williams, S.M., An, J.Y., Edson, J., Watts, M., Murigneux, V., Whitehouse, A.J., Jackson, C.J., Bellgrove, M.A., Cristino, A.S., and Claudianos, C. (2019). An integrative analysis of non-coding regulatory DNA variations associated with autism spectrum disorder. Mol. Psychiatr. 24: 1707\u20131719, https:\/\/doi.org\/10.1038\/s41380-018-0049-x.","DOI":"10.1038\/s41380-018-0049-x"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_156","doi-asserted-by":"crossref","unstructured":"Williams, L.A. and LaSalle, J.M. (2022). Future prospects for epigenetics in autism spectrum disorder. Mol. Diagn. Ther. 26: 569\u2013579, https:\/\/doi.org\/10.1007\/s40291-022-00608-z.","DOI":"10.1007\/s40291-022-00608-z"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_157","doi-asserted-by":"crossref","unstructured":"Wright, D., Kenny, A., Mizen, L.A., McKechanie, A.G., and Stanfield, A.C. (2025). Profiling autism and attention deficit hyperactivity disorder traits in children with SYNGAP1-related intellectual disability. J.\u00a0Autism Dev. Disord. 55: 297\u2013309, https:\/\/doi.org\/10.1007\/s10803-023-06162-9.","DOI":"10.1007\/s10803-023-06162-9"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_158","doi-asserted-by":"crossref","unstructured":"Wu, Z., Qin, J., You, Y., Ma, Y., Jia, M., Wang, L., Lu, T., Yue, W., Ruan, Y., Zhang, D., et al.. (2017). Genetic variants in the transcription regulatory region of MEGF10 are associated with autism in Chinese Han population. Sci. Rep. 7: 2292, https:\/\/doi.org\/10.1038\/s41598-017-02348-1.","DOI":"10.1038\/s41598-017-02348-1"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_159","doi-asserted-by":"crossref","unstructured":"Xie, Z., Eagleson, K.L., Wu, H.-H., and Levitt, P. (2016). Hepatocyte growth factor modulates MET receptor tyrosine kinase and \u03b2-catenin functional interactions to enhance synapse formation. Eneuro 3, https:\/\/doi.org\/10.1523\/eneuro.0074-16.2016.","DOI":"10.1523\/ENEURO.0074-16.2016"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_160","doi-asserted-by":"crossref","unstructured":"Xie, X., Li, L., Wu, H., Hou, F., Chen, Y., Xue, Q., Zhou, Y., Zhang, J., Gong, J., and Song, R. (2021). Comprehensive integrative analyses identify TIGD5 rs75547282 as a risk variant for autism spectrum disorder. Autism Res. 14: 631\u2013644, https:\/\/doi.org\/10.1002\/aur.2466.","DOI":"10.1002\/aur.2466"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_161","doi-asserted-by":"crossref","unstructured":"Xing, J., Kimura, H., Wang, C., Ishizuka, K., Kushima, I., Arioka, Y., Yoshimi, A., Nakamura, Y., Shiino, T., Oya-Ito, T., et al.. (2016). Resequencing and association analysis of six PSD-95-related genes as possible susceptibility genes for schizophrenia and autism spectrum disorders. Sci. Rep. 6: 27491, https:\/\/doi.org\/10.1038\/srep27491.","DOI":"10.1038\/srep27491"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_162","doi-asserted-by":"crossref","unstructured":"Xu, X., Tan, L., and Zhang, X. (2025). Prenatal exposure to valproic acid may alter CD200\/CD200R signaling pathways in a rat model of autism spectrum disorder. Alpha Psychiatry 26: 39444, https:\/\/doi.org\/10.31083\/ap39444.","DOI":"10.31083\/AP39444"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_163","doi-asserted-by":"crossref","unstructured":"Xu XiaoJuan, X.X., Xiong ZhiMin, X.Z., Zhang Lusi, Z.L., Liu YaLan, L.Y., Lu Lina, L.L., Peng Yu, P.Y., Guo Hui, G.H., Zhao JingPing, Z.J., Xia Kun, X.K., and Hu ZhengMao, H.Z. (2014). Variations analysis of NLGN3 and NLGN4X gene in Chinese autism patients. Mol. Biol. Rep. 41: 4133\u20134140, https:\/\/doi.org\/10.1007\/s11033-014-3284-5.","DOI":"10.1007\/s11033-014-3284-5"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_164","doi-asserted-by":"crossref","unstructured":"Xu, X., Xiong, Z., Zhang, L., Liu, Y., Lu, L., Peng, Y., Guo, H., Zhao, J., Xia, K., and Hu, Z. (2014). Variations analysis of NLGN3 and NLGN4X gene in Chinese autism patients. Mol. Biol. Rep. 41: 4133\u20134140, https:\/\/doi.org\/10.1007\/s11033-014-3284-5.","DOI":"10.1007\/s11033-014-3284-5"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_165","doi-asserted-by":"crossref","unstructured":"Yan, J., Feng, J., Schroer, R., Li, W., Skinner, C., Schwartz, C.E., Cook Jr, E.H., and Sommer, S.S. (2008). Analysis of the neuroligin 4Y gene in patients with autism. Psychiatr. Genet. 18: 204\u2013207, https:\/\/doi.org\/10.1097\/ypg.0b013e3282fb7fe6.","DOI":"10.1097\/YPG.0b013e3282fb7fe6"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_166","doi-asserted-by":"crossref","unstructured":"Yang, F., You, H., Mizui, T., Ishikawa, Y., Takao, K., Miyakawa, T., Li, X., Bai, T., Xia, K., Zhang, L., et al.. (2024). Inhibiting proBDNF to mature BDNF conversion leads to ASD-like phenotypes in\u00a0vivo. Mol. Psychiatr. 29: 3462\u20133474, https:\/\/doi.org\/10.1038\/s41380-024-02595-5.","DOI":"10.1038\/s41380-024-02595-5"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_167","doi-asserted-by":"crossref","unstructured":"Yao, S. and Kendrick, K.M. (2025). How does oxytocin modulate human behavior? Mol. Psychiatr.: 1\u201313, https:\/\/doi.org\/10.1038\/s41380-025-02898-1.","DOI":"10.1038\/s41380-025-02898-1"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_168","doi-asserted-by":"crossref","unstructured":"Yin, H., Wang, Z., Liu, J., Li, Y., Liu, L., Huang, P., Wang, W., Shan, Z., Sun, R., Shen, J., et al.. (2023). Dysregulation of immune and metabolism pathways in maternal immune activation induces an increased risk of autism spectrum disorders. Life Sci. 324: 121734, https:\/\/doi.org\/10.1016\/j.lfs.2023.121734.","DOI":"10.1016\/j.lfs.2023.121734"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_169","doi-asserted-by":"crossref","unstructured":"Yip, J., Soghomonian, J.-J., and Blatt, G.J. (2007). Decreased GAD67 mRNA levels in cerebellar purkinje cells in autism: pathophysiological implications. Acta Neuropathol. 113: 559\u2013568, https:\/\/doi.org\/10.1007\/s00401-006-0176-3.","DOI":"10.1007\/s00401-006-0176-3"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_170","doi-asserted-by":"crossref","unstructured":"Yuan, X., Chen, L., and Saffen, D. (2024). Allele-specific regulation of the candidate autism liability gene RAI1 by the enhancer variant rs4925102 (C\/G). Genes 15: 460, https:\/\/doi.org\/10.3390\/genes15040460.","DOI":"10.3390\/genes15040460"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_171","doi-asserted-by":"crossref","unstructured":"Zare, S., Mashayekhi, F., and Bidabadi, E. (2017). The association of CNTNAP2 rs7794745 gene polymorphism and autism in Iranian population. J.\u00a0Clin. Neurosci. 39: 189\u2013192, https:\/\/doi.org\/10.1016\/j.jocn.2017.01.008.","DOI":"10.1016\/j.jocn.2017.01.008"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_172","doi-asserted-by":"crossref","unstructured":"Zhang, C., Atasoy, D., Ara\u00e7, D., Yang, X., Fucillo, M.V., Robison, A.J., Ko, J., Brunger, A.T., and S\u00fcdhof, T.C. (2010). Neurexins physically and functionally interact with GABAA receptors. Neuron 66: 403\u2013416, https:\/\/doi.org\/10.1016\/j.neuron.2010.04.008.","DOI":"10.1016\/j.neuron.2010.04.008"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_173","doi-asserted-by":"crossref","unstructured":"Zhang, S.Q., Fleischer, J., Al-Kateb, H., Mito, Y., Amarillo, I., and Shinawi, M. (2020). Intragenic CNTN4 copy number variants associated with a spectrum of neurobehavioral phenotypes. Eur. J.\u00a0Med. Genet. 63: 103736, https:\/\/doi.org\/10.1016\/j.ejmg.2019.103736.","DOI":"10.1016\/j.ejmg.2019.103736"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_174","doi-asserted-by":"crossref","unstructured":"Zhang, L., Geng, C., Li, S., Tang, Q., Liu, P., Liu, W., Qiu, G., Li, A., Hu, A., and Chen, F. (2024). Anterior piriform cortex dysfunction underlies autism spectrum disorders-related olfactory deficits in Fmr1 conditional deletion mice. Neuropsychopharmacology 50: 798\u2013807, https:\/\/doi.org\/10.1038\/s41386-024-02027-6.","DOI":"10.1038\/s41386-024-02027-6"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_175","doi-asserted-by":"crossref","unstructured":"Zhang, L., Qin, Y., Gong, X., Peng, R., Cai, C., Zheng, Y., Du, Y., and Wang, H. (2019). A promoter variant in ZNF804A decreasing its expression increases the risk of autism spectrum disorder in the han Chinese population. Transl. Psychiatry 9: 31, https:\/\/doi.org\/10.1038\/s41398-019-0369-x.","DOI":"10.1038\/s41398-019-0369-x"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_176","doi-asserted-by":"crossref","unstructured":"Zhubi, A., Chen, Y., Guidotti, A., and Grayson, D.R. (2017). Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects. Int. J.\u00a0Dev. Neurosci. 62: 63\u201372, https:\/\/doi.org\/10.1016\/j.ijdevneu.2017.02.003.","DOI":"10.1016\/j.ijdevneu.2017.02.003"},{"key":"2025121816130086355_j_revneuro-2025-0040_ref_177","doi-asserted-by":"crossref","unstructured":"Zorio, D.A., Jackson, C.M., Liu, Y., Rubel, E.W., and Wang, Y. (2017). Cellular distribution of the fragile X mental retardation protein in the mouse brain. J.\u00a0Comp. Neurol. 525: 818\u2013849, https:\/\/doi.org\/10.1002\/cne.24100.","DOI":"10.1002\/cne.24100"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0040\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0040\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:15:25Z","timestamp":1766074525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0040\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":179,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,6,13]]},"published-print":{"date-parts":[[2025,12,17]]}},"alternative-id":["10.1515\/revneuro-2025-0040"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2025-0040","relation":{},"ISSN":["0334-1763","2191-0200"],"issn-type":[{"value":"0334-1763","type":"print"},{"value":"2191-0200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}